Oxford COVID vaccine paper highlights lingering unknowns about results
The Oxford–AstraZeneca partnership is the first major developer to publish detailed data from phase III trials.
The Oxford–AstraZeneca partnership is the first major developer to publish detailed data from phase III trials.
Living things depend on water, but it breaks down DNA and other key molecules. So how did the earliest cells deal with the water paradox?
Recent work on optical computing for artificial intelligence applications is reviewed and the potential and challenges of all-optical and hybrid optical networks are discussed.